MATTHEW PERRONE NICKY FORSTER

Advertisment

Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds

WASHINGTON (AP) — Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory...

MATTHEW PERRONE NICKY FORSTER

Advertisment